Company News For Dec 24, 2019

Zacks Equity Research Published on December 24, 2019

Shares of Aurora Cannabis Inc. (ACB - Free Report) dropped 10.7% after it announced that Chief Corporate Officer Cam Battley has left the company
Shares of Apache Corporation (APA - Free Report) jumped 17.3% after the company announced an agreement to acquire a 50% working interest of French company Total SA in Block 58 of the offshore Guyana-Suriname basin
Shares of Intra-Cellular Therapies, Inc. (ITCI - Free Report) soared 193.5% after the company announced that it has received FDA approval for CAPLYTA, the treatment of schizophrenia in adults
Shares of Sarepta Therapeutics, Inc. (SRPT - Free Report) rose 7.5% after the company announced it has entered into a partnership with Roche, which will provide Sarepta an exclusive right to launch and commercialize SRP-9001 outside the United States

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.